|
|
|
|
| Advertisement |
 |
|
|
| Pricing |
 |
|
The WHO Fair Pricing Forum |
Ed Schoonveld reviews the key topics discussed at the World Health Organization's second Fair Pricing Forum, held in Johannesburg, South Africa last month
… /Read more/ |
|
|
| CFO Focus |
 |
|
Survey Spotlights the CFO's Strategic Rise |
Findings support the belief that today's pharma finance teams should be engaged across all functional areas, including regulatory, supply chain, manufacturing, and commercial. What does that mean for current and future CFOs in the industry?
… /Read more/ |
|
|
|
| Sales |
 |
|
|
|
| Industry update |
| //
Enzyre (Nijmegen, The Netherlands) named Dirk Pollet as Chief Executive Officer.
Avadel Pharmaceuticals (Dublin, Ireland) appointed Jordan Dubow, M.D., as Chief Medical Officer.
//
Crescendo Biologics (Cambridge, UK) appointed Theodora Harold, formerly the company's CFO, as CEO. She succeeds Peter Pack, who stepped down from the CEO position on May 1.
//
Metrion Biosciences named Dr. Andrew Southan as Chief Executive Officer. Dr. Southan was previously the company's Chief Operating Officer.
//
Immunocore (Abingdon, UK) appointed Dr. Mohammed Dar as Head of Clinical Development and Chief Medical Officer.
//
Cambridge Healthcare Research (Cambridge, UK) announced the appointment of Stella Wooder as a strategic adviser.
//
Polyphor (Allschwil, Switzerland) appointed Gökhan Batur to the newly created position of Chief Commercial Officer.
|
|
|
|
|
|
|
|
|
